Correlation Between Madrigal Pharmaceuticals and Navidea Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Navidea Biopharmaceutica.
Diversification Opportunities for Madrigal Pharmaceuticals and Navidea Biopharmaceutica
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Madrigal and Navidea is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Navidea Biopharmaceutica go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Navidea Biopharmaceutica
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.61 times more return on investment than Navidea Biopharmaceutica. However, Madrigal Pharmaceuticals is 1.64 times less risky than Navidea Biopharmaceutica. It trades about 0.03 of its potential returns per unit of risk. Navidea Biopharmaceuticals is currently generating about -0.2 per unit of risk. If you would invest 22,303 in Madrigal Pharmaceuticals on June 9, 2024 and sell it today you would earn a total of 2,086 from holding Madrigal Pharmaceuticals or generate 9.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 2.41% |
Values | Daily Returns |
Madrigal Pharmaceuticals vs. Navidea Biopharmaceuticals
Performance |
Timeline |
Madrigal Pharmaceuticals |
Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Madrigal Pharmaceuticals and Navidea Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Madrigal Pharmaceuticals and Navidea Biopharmaceutica
The main advantage of trading using opposite Madrigal Pharmaceuticals and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.Madrigal Pharmaceuticals vs. Enveric Biosciences | Madrigal Pharmaceuticals vs. NovaBay Pharmaceuticals |
Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics | Navidea Biopharmaceutica vs. ARCA Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |